Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,541 | 348 | 78.9% |
| Travel and Lodging | $1,902 | 6 | 19.9% |
| Education | $116.44 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Terumo Medical Corporation | $2,007 | 8 | $0 (2018) |
| Medtronic Vascular, Inc. | $1,114 | 44 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $835.38 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $732.27 | 60 | $0 (2024) |
| Boston Scientific Corporation | $645.33 | 15 | $0 (2024) |
| ABIOMED | $502.83 | 9 | $0 (2022) |
| Amgen Inc. | $495.67 | 22 | $0 (2024) |
| PFIZER INC. | $373.62 | 22 | $0 (2024) |
| Abbott Laboratories | $335.89 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $307.55 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,749 | 77 | Novartis Pharmaceuticals Corporation ($324.65) |
| 2023 | $402.43 | 14 | E.R. Squibb & Sons, L.L.C. ($141.50) |
| 2022 | $450.92 | 6 | Abbott Laboratories ($225.70) |
| 2021 | $371.81 | 12 | ABIOMED ($99.50) |
| 2020 | $326.74 | 13 | Medtronic Vascular, Inc. ($192.60) |
| 2019 | $1,058 | 61 | Amgen Inc. ($202.89) |
| 2018 | $3,513 | 88 | Terumo Medical Corporation ($2,007) |
| 2017 | $1,687 | 88 | Medtronic Vascular, Inc. ($531.37) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/29/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $41.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $24.28 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $23.40 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/19/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $148.91 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2024 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $22.79 | General |
| 10/04/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $48.21 | General |
| Category: VTE | ||||||
| 10/03/2024 | Abbott Laboratories | PRESSUREWIRE (Device) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Vascular | ||||||
| 09/26/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $37.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 5,223 | 7,116 | $2.0M | $491,645 |
| 2022 | 40 | 5,446 | 7,318 | $1.9M | $496,762 |
| 2021 | 31 | 5,175 | 7,284 | $1.5M | $411,938 |
| 2020 | 33 | 3,772 | 4,989 | $1.1M | $271,414 |
All Medicare Procedures & Services
151 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 784 | 1,113 | $331,674 | $99,706 | 30.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 237 | 238 | $323,680 | $74,676 | 23.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 501 | 520 | $297,930 | $56,373 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 713 | 798 | $161,196 | $45,813 | 28.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 153 | 305 | $84,180 | $26,932 | 32.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 131 | 524 | $81,220 | $22,265 | 27.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 301 | 314 | $64,370 | $16,118 | 25.0% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 82 | 163 | $69,601 | $15,106 | 21.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 129 | 135 | $51,300 | $13,223 | 25.8% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 84 | 84 | $64,344 | $12,346 | 19.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 58 | 59 | $54,280 | $11,250 | 20.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $46,056 | $11,124 | 24.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 236 | 236 | $64,192 | $11,077 | 17.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 784 | 990 | $57,420 | $9,569 | 16.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 22 | 23 | $39,882 | $9,568 | 24.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 74 | 135 | $27,270 | $8,008 | 29.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 87 | 87 | $26,013 | $6,286 | 24.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 45 | 45 | $31,545 | $5,448 | 17.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 103 | 228 | $22,800 | $5,050 | 22.1% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 44 | 232 | $17,168 | $4,530 | 26.4% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 42 | 55 | $19,910 | $4,436 | 22.3% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $13,836 | $3,219 | 23.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 24 | 150 | $12,150 | $2,868 | 23.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 71 | 103 | $12,154 | $2,726 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $7,619 | $2,603 | 34.2% |
About Dr. Jay Kalan, MD
Dr. Jay Kalan, MD is a Cardiovascular Disease healthcare provider based in Hilton Head Island, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306835541.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Kalan, MD has received a total of $9,559 in payments from pharmaceutical and medical device companies, with $1,749 received in 2024. These payments were reported across 359 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,541).
As a Medicare-enrolled provider, Kalan has provided services to 19,616 Medicare beneficiaries, totaling 26,707 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 151 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Hilton Head Island, SC
- Active Since 10/20/2005
- Last Updated 08/07/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1306835541
Products in Payments
- Optitorque (Device) $1,992
- XARELTO (Drug) $732.27
- ENTRESTO (Drug) $629.73
- Impella (Device) $502.83
- Micra (Device) $369.69
- ELIQUIS (Drug) $336.62
- Repatha (Biological) $332.02
- WATCHMAN (Device) $233.27
- BRILINTA (Drug) $207.61
- LEQVIO (Drug) $205.65
- CHANTIX (Drug) $194.32
- LifeVest (Device) $193.47
- WATCHMAN FLX (Device) $190.82
- Azure (Device) $186.95
- VERQUVO (Drug) $181.32
- Claria MRI (Device) $167.05
- Corlanor (Drug) $163.65
- Barostim Neo System (Device) $155.70
- MULTAQ (Drug) $145.76
- FLOWTRIEVER CATHETER, S (Device) $145.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.